AstraZeneca (AZN)
(Delayed Data from NSDQ)
$78.36 USD
+0.23 (0.29%)
Updated Jul 29, 2024 04:00 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | 1.06 |
EPS Last Quarter | 0.99 |
Last EPS Surprise | 3.13% |
ABR | 1.57 |
Earnings ESP
|
1.61% |
---|---|
Current Year | 4.05 |
Next Year | 4.72 |
EPS (TTM) | 3.62 |
P/E (F1) | 19.36 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 13.08B | 13.79B | 52.15B | 56.67B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 13.66B | 14.30B | 53.00B | 58.15B |
Low Estimate | 12.57B | 13.14B | 50.74B | 54.98B |
Year ago Sales | 11.49B | 12.02B | 45.81B | 52.15B |
Year over Year Growth Est. | 13.80% | 14.66% | 13.83% | 8.68% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.06 | 1.00 | 4.05 | 4.72 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | 1.04 | 1.29 | 4.02 | 5.13 |
High Estimate | 1.24 | 1.09 | 4.17 | 5.31 |
Low Estimate | 0.98 | 0.77 | 4.00 | 4.48 |
Year ago EPS | 0.87 | 0.73 | 3.63 | 4.05 |
Year over Year Growth Est. | 21.84% | 36.99% | 11.57% | 16.54% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 2 | 2 |
Up Last 30 Days | 1 | 0 | 2 | 2 |
Up Last 60 Days | 1 | 0 | 2 | 3 |
Down Last 7 Days | 0 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 2 | 1 | 3 |
Down Last 60 Days | 1 | 2 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.06 | 1.00 | 4.05 | 4.72 |
7 Days Ago | 1.07 | 1.05 | 4.04 | 4.69 |
30 Days Ago | 1.02 | 1.14 | 4.03 | 4.68 |
60 Days Ago | 1.02 | 1.14 | 4.03 | 4.68 |
90 Days Ago | 1.06 | 1.15 | 4.00 | 4.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.08 | 0.97 | 4.08 | 4.75 |
Zacks Consensus Estimate | 1.06 | 1.00 | 4.05 | 4.72 |
Earnings ESP | 1.61% | -2.67% | 0.74% | 0.79% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.99 | 1.03 | 0.73 | 0.87 | NA |
Estimate | 0.96 | 0.95 | 0.74 | 0.80 | NA |
Difference | 0.03 | 0.08 | -0.01 | 0.07 | 0.04 |
Surprise | 3.13% | 8.42% | -1.35% | 8.75% | 4.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more